Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal

Area of Science:

• Oncology
• Cancer Biology
• Genetics

Background:

• Oncogene addiction describes tumor cell death upon oncogene inhibition, driving targeted cancer therapy development.
• Solid tumors frequently exhibit chromosomal instability due to mitotic checkpoint pathway deregulation.
• The impact of chromosomal instability on oncogene addiction remains unexplored.

Purpose of the Study:

• To investigate the effect of chromosomal instability on oncogene addiction in Kras-driven lung tumors.
• To determine if transient mitotic checkpoint gene overexpression influences tumor recurrence after oncogene inhibition.

Main Methods:

• Overexpression of the mitotic checkpoint gene Mad2 in mice to induce chromosome instability.
• Inhibition of Kras in Kras-driven lung tumors to assess initial regression.
• Monitoring tumor recurrence rates and analyzing the ploidy and pathway activation of recurrent tumors.

Main Results:

• Mad2 overexpression and induced chromosome instability did not affect the initial regression of Kras-driven lung tumors upon Kras inhibition.
• Tumors experiencing transient Mad2 overexpression and chromosome instability showed markedly elevated recurrence rates.
• Recurrent tumors were highly aneuploid with diverse activation of pro-proliferative pathways.

Conclusions:

• Early chromosomal instability may not impede initial treatment response but significantly contributes to tumor relapse.
• Aneuploidy and varied pro-proliferative pathway activation in recurrent tumors suggest mechanisms for overcoming targeted therapy.
• This study highlights chromosomal instability as a critical factor in cancer treatment failure and relapse.